Abstract:Alphaherpesviruses, including herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2), and varicella-zoster virus (VZV), infect a diverse array of hosts, spanning both humans and animals. Alphaherpesviruses have developed a well-adapted relationship with their hosts through long-term evolution. Some alphaherpesviruses exhibit a typical neurotropic characteristic, which has garnered widespread attention and in-depth research. Virus latency involves the retention of viral genomes without producing infectious viruses. However, under stress, this can be reversed, resulting in lytic infection. Such reactivation events can lead to recurrent infections, manifesting as diseases like herpes labialis, genital herpes, and herpes zoster. Reactivation is a complex process influenced by both viral and host factors, and identifying how latency and reactivation work is vital to developing new antiviral therapies. Recent research highlights a complex interaction among the virus, neurons, and the immune system in regulating alphaherpesvirus latency and reactivation. Neurotropic alphaherpesviruses can breach host barriers to infect neurons, proliferate extensively within their cell bodies, and establish latent infections or spread further. Whether infecting neurons or spreading further, the virus undergoes transmission along axons or dendrites, making this process an indispensable part of the viral life cycle and a critical factor influencing the virus's invasion of the nervous system. Research on the transmission process of neurotropic alphaherpesviruses within neurons can not only deepen our understanding of the virus but can also facilitate the targeted development of corresponding vaccines. This review concentrates on the relationship between the transmission, latency, and activation of alphaherpesviruses within neurons, summarizes recent advancements in the field, and discusses how these findings can inform the design of live virus vaccines for alphaherpesviruses.

Advances in the immunoescape mechanisms exploited by alphaherpesviruses

[Mechanisms of Herpes Simplex Virus Latency and Reactivation].

ICP22/IE63 Mediated Transcriptional Regulation and Immune Evasion: Two Important Survival Strategies for Alphaherpesviruses

Recent Advances in the Study of Alphaherpesvirus Latency and Reactivation: Novel Guidance for the Design of Herpesvirus Live Vector Vaccines

Innate immune evasion of alphaherpesvirus tegument proteins

Evasion of the Cell-Mediated Immune Response by Alphaherpesviruses

A review of HSV pathogenesis, vaccine development, and advanced applications

The precise function of alphaherpesvirus tegument proteins and their interactions during the viral life cycle

Alphaherpesvirus-vectored Vaccines Against Animal Diseases: Current Progress

Alphaherpesvirus Glycoprotein E: A Review of Its Interactions with Other Proteins of the Virus and Its Application in Vaccinology

Mechanism of herpesvirus UL24 protein regulating viral immune escape and virulence

Evasion of I Interferon-Mediated Innate Immunity by Pseudorabies Virus

Evasion of the Antiviral Innate Immunity by PRV

Insight into the Interaction Mechanism of Pseudorabies Virus Infection

The Quest for Immunity: Exploring Human Herpesviruses as Vaccine Vectors

Mechanism of herpesvirus protein kinase UL13 in immune escape and viral replication

Evasion of Antiviral Innate Immunity by Porcine Reproductive and Respiratory Syndrome Virus

Research Progress on the Molecular Mechanism of Immune Escape of Porcine Reproductive and Respiratory Syndrome Virus

Advances in the Research of Viral Infection and Evasion of Immune Response

Evasion strategies of porcine reproductive and respiratory syndrome virus

An updated review of HSV-1 infection-associated diseases and treatment, vaccine development, and vector therapy application